Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Posted On: 2021-03-06 04:25:29 (Time Zone: Arizona, USA)


Aarti Speciality Chemicals Limited (ASCL), a wholly-owned subsidiary of Aarti Drugs Limited (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India's recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector.

Government of India's Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Synthesis based - at least 70%) with a total outlay of Rs. 6,940 crores. The objective of the scheme is achieving self-reliance and reducing import dependence in these critical 'Key Starting Materials (KSMs) / Drug Intermediates / Active Pharmaceutical Ingredients (APIs)' in the country. The tenure of the scheme is from FY21 to FY30.

The applications under four different Target Segments were invited with 30 November 2020 as the last date. In total, 215 applications were received for the 41 products spread across the 4 Target Segments.

Aarti Speciality Chemicals Limited, a wholly-owned subsidiary of Aarti Drugs Limited received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum under Target Segment III (Key Chemical Synthesis Based KSMs/Drug Intermediates). The rate incentive will be 10 per cent of sales value per annum for a period of 6 years - FY23 to FY28.

Commenting on the Government's approval Mr. Adhish Patil, Chief Financial Officer - Aarti Drugs Limited said: "We welcome the government's approval to our application under PLI scheme to manufacture 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum. This is a very positive development for us, as it will help the company to diversify its product portfolio, increase the top-line and enhance the profitability & margin profile of the company.

Backed by a strong Balance Sheet, and robust free cash flow generation, the committed capex will be funded through a mix of debt and internal accruals. We are expecting the capex for this project to be spread over a period of 18 months. This will further reduce our dependence on imports.

As a strategy, we have always focused on import substitution and will continue to pursue various opportunities. We remain committed to "Atmanirbhar Bharat" vision of the Government."

Shares of AARTI DRUGS LTD. was last trading in BSE at Rs.667.1 as compared to the previous close of Rs. 691.05. The total number of shares traded during the day was 18902 in over 1169 trades.

The stock hit an intraday high of Rs. 696.55 and intraday low of 660.95. The net turnover during the day was Rs. 12711803.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Subex to launch new AI Automation Platform on April 22, 2021

Easy Trip Planners Ltd board declares interim dividend of Rs. 2

Firstsource Solutions Ltd board to consider Q4, FY21 results on May 11, 2021

Happiest Minds wins Times Ascent - World HRD Congress HR Excellence Awards 2021

Indian Energy Exchange commences Cross Border Electricity Trade through its platform

Caplin Steriles gets USFDA approval for Milrinone Lactate Injection

NTPC Ltd declares commercial operation of 85 MW Bilhaur Solar PV Project

G E Shipping takes delivery of a Secondhand Midsize Gas Carrier 'Jag Vikram'

Copenhagen Fintech welcomes Infosys to Elevate Fintech Innovation

Ambuja 'Kawach' recognized globally by Solar Impulse Foundation's efficient solution label

India Ratings assigns Sobha 'IND AA-'/Stable

Sarda Energy & Minerals Ltd updates on Madhya Bharat Power Corporation Ltd

Can Fin Homes Ltd board to consider dividend, Q4, FY21 results on April 30, 2021

HCL to drive end-to-end IT transformation at UD Trucks

WeP Solutions Ltd rights issue to close today

IFGL Refractories Ltd board to consider FY21 results, dividend on May 22, 2021

United Breweries Ltd board to recommend dividend, consider Q4, FY21 results on April 27, 2021

Goa Carbon Limited temporarily shuts down Goa unit for maintenance from April 17, 2021

Sonata Software Ltd board to approve Q4, FY2021 results on May 12, 2021

KPIT Technologies Ltd board to consider dividend, Q4, FY21 results on April 28, 2021

Macrotech Developers Ltd to list on April 19, 2021

KSB Ltd board to approve Q1CY21 results on April 28, 2021

INOX Leisure Limited Ratings downgraded to 'CRISIL A+/Negative/CRISIL A1'

Bhansali Engineering Polymers Ltd Board approves dividend of Rs. 1 for FY21

All Wonderla Amusement Parks will open only on Friday, Saurday and Sunday from April 19, 2021

Bhansali Engineering Polymers Ltd Q4FY21 consolidated PAT jumps to Rs. 163.48 crore

Kalyan Jewellers ushers in the wedding season with its latest Muhurat Campaign

IndusInd Bank Ltd board to consider Q4, FY21 results on April 30, 2021

Jubilant Ingrevia Ltd appoints two directors to its board

Wockhardt Ltd board to consider raising funds through NCDs on April 21, 2021

Trident Ltd celebrating Mission Day with a special discount coupon to shareholders

S.P. Capital Financing Ltd approves selling of shares in Pride And Expert Properties Private Limited

IIFL Securities Limited to acquire Category II AIF from IIFL Wealth Management Ltd

HDFC Bank Limited to raise up to Rs. 50,000 crore

Indo Asian Finance Ltd to consider allotment of 60 lakh shares on April 20, 2021

KEC International Limited Resumption of WKTL Transmission Project

IIFL Wealth Management Ltd to sell AIF Category-II business to IIFL Management Services Ltd

International Travel House Ltd Q4FY21 loss at Rs. 6.70 crore

Gujarat Hotels Ltd Q4FY21 net profit slides YoY, QoQ

ICICI Lombard General Insurance Company Limited board recommends final dividend of Rs. 4

Gujarat Hotels Ltd board recommends dividend of Rs. 1.80 for FY21

ICICI Lombard General Insurance Company Ltd reports Rs. 345.68 crore PAT in Q4FY21

HDFC Bank Ltd's gross NPAs at 1.32%, reduces QoQ

HDB Financial Services Ltd's gross NPAs at 3.9% as of March 31, 2021

HDFC Securities Ltd reports PAT of Rs. 253.1 crore in Q4FY21

Career Point signed MOU with Ministry of Social Justice and Empowerment for tutorial services

HDFC Bank's balance sheet increases 14.1% YoY

Indiamart arm to acquire 22% in Truckhall Pvt Ltd

HDFC Bank Ltd Q4FY21 consolidated net profit slips QoQ to Rs. 8433.78 crore

CRISIL downgrades rating of PVR Ltd


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020